Clinical Trial Update: Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis [Phase 3]

View source ↗

Summary

Phase 3 trial updating the use of plasma exchange and glucocorticoids for ANCA-associated vasculitis, with completion and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatosis with Polyangiitis
• Microscopic Polyangiitis

Snippet

Sponsor: University of Pennsylvania | Conditions: Granulomatosis With Polyangiitis (Wegener's) (GPA), Microscopic Polyangiitis (MPA) | Phase 3 | Status: COMPLETED | Results posted: 2020-05-26